Benzinga | Nov 9, 2020 04:10PM EST

Arcturus Therapeutics Q3 EPS $(0.92) Misses $(0.49) Estimate, Sales $2.33M Miss $3.00M Estimate

Arcturus Therapeutics (NASDAQ:ARCT) reported quarterly losses of $(0.92) per share which missed the analyst consensus estimate of $(0.49) by 87.76 percent. This is a 64.29 percent decrease over losses of $(0.56) per share from the same period last year. The company reported quarterly sales of $2.33 million which missed the analyst consensus estimate of $3.00 million by 22.23 percent. This is a 29.69 percent decrease over sales of $3.32 million the same period last year.